New Jersey 2026-2027 Regular Session

New Jersey Senate Bill S2345

Introduced
1/13/26  

Caption

"Patient and Provider Protection Act."

Impact

One of the critical components of S2345 is its stipulation that any agreement between a PBM and a manufacturer is deemed invalid if the contract includes any rebate conditional upon the exclusion of generic drugs from coverage. This section of the bill seeks to promote the use of more affordable generic medications in an effort to lower healthcare costs for consumers. It also reiterates the importance of equitable reimbursement rates for all pharmacies, whether they be contracted or independent, to facilitate fair competition in the prescription drug market.

Summary

Senate Bill S2345, known as the 'Patient and Provider Protection Act,' aims to establish new regulations governing the actions of pharmacy benefits managers (PBMs) within the healthcare system. The bill mandates that PBMs hold a fiduciary duty to prioritize the long-term health outcomes of covered persons, thereby enhancing accountability in their operations. Furthermore, the legislation prohibits PBMs from engaging in misleading marketing practices that could influence patients to opt for certain pharmacies over others, specifically contracted or network pharmacies.

Contention

The legislation defines how PBMs must reimburse pharmacies, specifying that a contracted pharmacy or network pharmacy must be reimbursed at a rate that is at least equal to their acquisition cost of the prescription drug. Independent pharmacies are also required to receive competitive reimbursement rates. However, the bill is contentious as it presumes contracts between PBMs and pharmacies to be 'contracts of adhesion' in case of disputes, which opponents argue may lead to increased scrutiny of contractual terms and could discourage agreements or lead to litigation between the parties involved. Additionally, the bill requires the establishment of a pharmacy and therapeutics committee to manage formulary systems, ensuring no decision unfairly favors higher-cost drugs over generic options.

Implementation

S2345 is set to take effect on the first day of the seventh month following its enactment. The regulations will apply to all contracts and agreements that are entered into, renewed, modified, or amended after the bill's effective date. In anticipation of its enactment, the Commissioner of Banking and Insurance is authorized to take administrative action necessary for its implementation.

Companion Bills

NJ A4953

Carry Over "Patient and Provider Protection Act."

NJ S3842

Carry Over "Patient and Provider Protection Act."

NJ A1502

Same As "Patient and Provider Protection Act."

Similar Bills

KS HB2551

Enacting the Kansas pharmacy services administrative organization act.

AR SB593

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; And To Create The Pharmacy Services Administrative Organization Act.

MS HB558

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.

MS HB1125

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.

AR SB475

To Establish The Pharmacy Services Administrative Organization Act; And To Regulate Pharmacy Services Administrative Organizations.

AZ HB2429

Pharmacy benefits; pharmacy management networks

AZ HB2813

Pharmacy benefits; workers' compensation

MS HB1119

Pharmacy benefit managers; revise provisions related to.